vs
STANDARD BIOTOOLS INC.（LAB）与RED RIVER BANCSHARES INC（RRBI）财务数据对比。点击上方公司名可切换其他公司
RED RIVER BANCSHARES INC的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$33.2M vs $19.6M），RED RIVER BANCSHARES INC净利率更高（34.4% vs -177.4%，领先211.8%），RED RIVER BANCSHARES INC同比增速更快（15.7% vs -11.5%），RED RIVER BANCSHARES INC自由现金流更多（$42.2M vs $-23.1M），过去两年RED RIVER BANCSHARES INC的营收复合增速更高（12.4% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Red River Bancshares Inc是一家美国地区性金融控股公司，通过旗下子公司红河银行开展业务，提供零售与商业银行服务，包含存款账户、个人及商业贷款、抵押贷款、财富管理等产品，主要服务路易斯安那州的本地社区及中小企业客户。
LAB vs RRBI — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $33.2M |
| 净利润 | $-34.7M | $11.4M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 42.8% |
| 净利率 | -177.4% | 34.4% |
| 营收同比 | -11.5% | 15.7% |
| 净利润同比 | -28.8% | 22.7% |
| 每股收益（稀释后） | $-0.09 | $1.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $33.2M | ||
| Q3 25 | $19.6M | $31.9M | ||
| Q2 25 | $21.8M | $30.5M | ||
| Q1 25 | $40.8M | $29.9M | ||
| Q4 24 | — | $28.7M | ||
| Q3 24 | $22.1M | $27.9M | ||
| Q2 24 | $22.5M | $26.9M | ||
| Q1 24 | $45.5M | $26.3M |
| Q4 25 | — | $11.4M | ||
| Q3 25 | $-34.7M | $10.8M | ||
| Q2 25 | $-33.5M | $10.2M | ||
| Q1 25 | $-26.0M | $10.4M | ||
| Q4 24 | — | $9.3M | ||
| Q3 24 | $-26.9M | $8.8M | ||
| Q2 24 | $-45.7M | $8.0M | ||
| Q1 24 | $-32.2M | $8.2M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 42.8% | ||
| Q3 25 | -168.5% | 41.9% | ||
| Q2 25 | -118.1% | 41.7% | ||
| Q1 25 | -80.8% | 43.0% | ||
| Q4 24 | — | 40.2% | ||
| Q3 24 | -120.9% | 38.8% | ||
| Q2 24 | -134.5% | 36.8% | ||
| Q1 24 | -132.2% | 38.5% |
| Q4 25 | — | 34.4% | ||
| Q3 25 | -177.4% | 33.8% | ||
| Q2 25 | -153.7% | 33.4% | ||
| Q1 25 | -63.8% | 34.6% | ||
| Q4 24 | — | 32.4% | ||
| Q3 24 | -122.0% | 31.4% | ||
| Q2 24 | -203.3% | 29.7% | ||
| Q1 24 | -70.6% | 31.1% |
| Q4 25 | — | $1.72 | ||
| Q3 25 | $-0.09 | $1.63 | ||
| Q2 25 | $-0.09 | $1.51 | ||
| Q1 25 | $-0.07 | $1.52 | ||
| Q4 24 | — | $1.36 | ||
| Q3 24 | $-0.07 | $1.27 | ||
| Q2 24 | $-0.12 | $1.16 | ||
| Q1 24 | $-0.27 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $213.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $365.1M |
| 总资产 | $539.6M | $3.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $213.4M | ||
| Q3 25 | $129.4M | $161.1M | ||
| Q2 25 | $158.6M | $210.4M | ||
| Q1 25 | $150.9M | $252.2M | ||
| Q4 24 | — | $269.0M | ||
| Q3 24 | $210.6M | $232.6M | ||
| Q2 24 | $269.8M | $213.1M | ||
| Q1 24 | $287.1M | $229.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $365.1M | ||
| Q3 25 | $399.7M | $351.3M | ||
| Q2 25 | $424.5M | $335.4M | ||
| Q1 25 | $454.6M | $333.3M | ||
| Q4 24 | — | $319.7M | ||
| Q3 24 | $489.3M | $324.3M | ||
| Q2 24 | $510.3M | $307.0M | ||
| Q1 24 | $577.3M | $299.3M |
| Q4 25 | — | $3.4B | ||
| Q3 25 | $539.6M | $3.2B | ||
| Q2 25 | $557.0M | $3.2B | ||
| Q1 25 | $579.6M | $3.2B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | $681.5M | $3.1B | ||
| Q2 24 | $708.7M | $3.0B | ||
| Q1 24 | $777.7M | $3.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $44.8M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $42.2M |
| 自由现金流率自由现金流/营收 | -118.1% | 127.2% |
| 资本支出强度资本支出/营收 | 4.5% | 7.8% |
| 现金转化率经营现金流/净利润 | — | 3.92× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $75.2M |
8季度趋势，按日历期对齐
| Q4 25 | — | $44.8M | ||
| Q3 25 | $-22.2M | $16.5M | ||
| Q2 25 | $-20.7M | $3.8M | ||
| Q1 25 | $-30.3M | $13.9M | ||
| Q4 24 | — | $38.3M | ||
| Q3 24 | $-27.9M | $17.4M | ||
| Q2 24 | $-39.0M | $2.4M | ||
| Q1 24 | $-62.5M | $14.4M |
| Q4 25 | — | $42.2M | ||
| Q3 25 | $-23.1M | $15.8M | ||
| Q2 25 | $-22.6M | $3.5M | ||
| Q1 25 | $-35.3M | $13.7M | ||
| Q4 24 | — | $33.4M | ||
| Q3 24 | $-30.1M | $17.0M | ||
| Q2 24 | $-41.0M | $1.4M | ||
| Q1 24 | $-63.3M | $13.4M |
| Q4 25 | — | 127.2% | ||
| Q3 25 | -118.1% | 49.6% | ||
| Q2 25 | -103.6% | 11.6% | ||
| Q1 25 | -86.6% | 45.7% | ||
| Q4 24 | — | 116.5% | ||
| Q3 24 | -136.4% | 60.9% | ||
| Q2 24 | -182.2% | 5.4% | ||
| Q1 24 | -138.9% | 50.8% |
| Q4 25 | — | 7.8% | ||
| Q3 25 | 4.5% | 2.1% | ||
| Q2 25 | 8.7% | 0.9% | ||
| Q1 25 | 12.4% | 0.9% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | 10.2% | 1.4% | ||
| Q2 24 | 8.6% | 3.6% | ||
| Q1 24 | 1.7% | 4.0% |
| Q4 25 | — | 3.92× | ||
| Q3 25 | — | 1.53× | ||
| Q2 25 | — | 0.37× | ||
| Q1 25 | — | 1.34× | ||
| Q4 24 | — | 4.11× | ||
| Q3 24 | — | 1.99× | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 1.76× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
RRBI
暂无分部数据
